| Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3 T Kawaguchi, T Yoshida, M Harada, T Hisamoto, Y Nagao, T Ide, ... The American journal of pathology 165 (5), 1499-1508, 2004 | 702 | 2004 |
| Expression of cyclooxygenase‐2 in human hepatocellular carcinoma: relevance to tumor dedifferentiation H Koga, S Sakisaka, M Ohishi, T Kawaguchi, E Taniguchi, K Sasatomi, ... Hepatology 29 (3), 688-696, 1999 | 622 | 1999 |
| Haematopoietic cell-specific CDM family protein DOCK2 is essential for lymphocyte migration Y Fukui, O Hashimoto, T Sanui, T Oono, H Koga, M Abe, A Inayoshi, ... Nature 412 (6849), 826-831, 2001 | 517 | 2001 |
| Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic review R Hashida, T Kawaguchi, M Bekki, M Omoto, H Matsuse, T Nago, ... Journal of hepatology 66 (1), 142-152, 2017 | 489 | 2017 |
| Clearance of HCV improves insulin resistance, beta-cell function, and hepatic expression of insulin receptor substrate 1 and 2 T Kawaguchi, T Ide, E Taniguchi, E Hirano, M Itou, S Sumie, Y Nagao, ... Official journal of the American College of Gastroenterology| ACG 102 (3 …, 2007 | 341 | 2007 |
| Luteolin promotes degradation in signal transducer and activator of transcription 3 in human hepatoma cells: an implication for the antitumor potential of flavonoids K Selvendiran, H Koga, T Ueno, T Yoshida, M Maeyama, T Torimura, ... Cancer research 66 (9), 4826-4834, 2006 | 265 | 2006 |
| Involvement of p21WAF1/Cip1, p27Kip1, and p18INK4c in troglitazone-induced cell-cycle arrest in human hepatoma cell lines H Koga, S Sakisaka, M Harada, T Takagi, S Hanada, E Taniguchi, ... Hepatology 33 (5), 1087-1097, 2001 | 240 | 2001 |
| Spreds, inhibitors of the Ras/ERK signal transduction, are dysregulated in human hepatocellular carcinoma and linked to the malignant phenotype of tumors T Yoshida, T Hisamoto, J Akiba, H Koga, K Nakamura, Y Tokunaga, ... Oncogene 25 (45), 6056-6066, 2006 | 209 | 2006 |
| Nuclear DNA fragmentation and expression of Bcl‐2 in primary biliary cirrhosis H Koga, S Sakisaka, M Ohishi, M Sata, K Tanikawa Hepatology 25 (5), 1077-1084, 1997 | 170 | 1997 |
| Early advanced hepatocellular carcinoma: evaluation of CT and MR appearance with pathologic correlation. TC Winter 3rd, K Takayasu, Y Muramatsu, H Furukawa, F Wakao, H Koga, ... Radiology 192 (2), 379-387, 1994 | 153 | 1994 |
| Telmisartan inhibits AGE-induced C-reactive protein production through downregulation of the receptor for AGE via peroxisome proliferator-activated receptor-gamma activation T Yoshida, S Yamagishi, K Nakamura, T Matsui, T Imaizumi, M Takeuchi, ... Diabetologia 49, 3094-3099, 2006 | 138 | 2006 |
| Endothelial progenitor cell transplantation improves the survival following liver injury in mice E Taniguchi, M Kin, T Torimura, T Nakamura, H Kumemura, S Hanada, ... Gastroenterology 130 (2), 521-531, 2006 | 125 | 2006 |
| Alterations in tight junctions differ between primary biliary cirrhosis and primary sclerosing cholangitis S Sakisaka, T Kawaguchi, E Taniguchi, S Hanada, K Sasatomi, H Koga, ... Hepatology 33 (6), 1460-1468, 2001 | 122 | 2001 |
| Serum C‐reactive protein levels predict survival in hepatocellular carcinoma S Nagaoka, T Yoshida, J Akiyoshi, J Akiba, T Torimura, H Adachi, ... Liver International 27 (8), 1091-1097, 2007 | 108 | 2007 |
| Troglitazone induces p27Kip1‐associated cell‐cycle arrest through down‐regulating Skp2 in human hepatoma cells H Koga, M Harada, M Ohtsubo, S Shishido, H Kumemura, S Hanada, ... Hepatology 37 (5), 1086-1096, 2003 | 105 | 2003 |
| Hydrogen peroxide overproduction in megamitochondria of troglitazone-treated human hepatocytes S Shishido, H Koga, M Harada, H Kumemura, S Hanada, E Taniguchi, ... Hepatology 37 (1), 136-147, 2003 | 105 | 2003 |
| Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label … S Qin, M Chen, AL Cheng, AO Kaseb, M Kudo, HC Lee, AC Yopp, J Zhou, ... The Lancet 402 (10415), 1835-1847, 2023 | 103 | 2023 |
| Cell cycle regulation by the Wee1 inhibitor PD0166285, pyrido [2, 3-d] pyimidine, in the B16 mouse melanoma cell line O Hashimoto, M Shinkawa, T Torimura, T Nakamura, K Selvendiran, ... BMC cancer 6, 1-11, 2006 | 95 | 2006 |
| Prophylactic lamivudine administration prevents exacerbation of liver damage in HBe antigen positive patients with hepatocellular carcinoma undergoing transhepatic arterial … H Nagamatsu, S Itano, S Nagaoka, J Akiyoshi, S Matsugaki, J Kurogi, ... Official journal of the American College of Gastroenterology| ACG 99 (12 …, 2004 | 87 | 2004 |
| Noncanonical Wnt11 inhibits hepatocellular carcinoma cell proliferation and migration T Toyama, HC Lee, H Koga, JR Wands, M Kim Molecular Cancer Research 8 (2), 254-265, 2010 | 82 | 2010 |
